Stocks · Health care · Biological Products, (No Diagnostic Substances)

Bio-Techne

TECH Clue Score45
United States Fiscal year ends June CIK 0000842023
$72.46 +0.01% Close, 9 Oct 2026
Price $72.46 −84.85% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue563.0Operating income120.6Net income76.1EPS, diluted2.03Fiscal year 2018Revenue643.0 +14.2%Operating income136.2Net income126.2 +65.8%EPS, diluted3.31Fiscal year 2019Revenue714.0 +11.0%Operating income146.7Net income96.1 −23.8%EPS, diluted2.47Fiscal year 2020Revenue738.7 +3.5%Operating income157.4Net income229.3 +138.7%EPS, diluted5.82Fiscal year 2021Revenue931.0 +26.0%Operating income237.3Net income140.4 −38.8%EPS, diluted0.87Fiscal year 2022Revenue1,105.6 +18.7%Operating income296.6Net income272.1 +93.8%EPS, diluted1.66Fiscal year 2023Revenue1,136.7 +2.8%Operating income298.9Net income285.3 +4.9%EPS, diluted1.76Fiscal year 2024Revenue1,159.1 +2.0%Operating income206.7Net income168.1 −41.1%EPS, diluted1.05Fiscal year 2025Revenue1,219.6 +5.2%Operating income102.3Net income73.4 −56.3%EPS, diluted0.46Fiscal year 2026Revenue1,215.0 −0.4%Operating income251.9Net income181.9 +147.8%EPS, diluted1.16
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 563.0 643.0 714.0 738.7 931.0 1,105.6 1,136.7 1,159.1 1,219.6 1,215.0
Growth +14.2% +11.0% +3.5% +26.0% +18.7% +2.8% +2.0% +5.2% −0.4%
Operating income 120.6 136.2 146.7 157.4 237.3 296.6 298.9 206.7 102.3 251.9
Net income 76.1 126.2 96.1 229.3 140.4 272.1 285.3 168.1 73.4 181.9
Growth +65.8% −23.8% +138.7% −38.8% +93.8% +4.9% −41.1% −56.3% +147.8%
EPS, diluted 2.03 3.31 2.47 5.82 0.87 1.66 1.76 1.05 0.46 1.16

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Gross margin66.5%Operating margin21.4%Net margin13.5%Free cash flow margin22.8%Fiscal year 2018Gross margin67.2%Operating margin21.2%Net margin19.6%Free cash flow margin23.2%Fiscal year 2019Gross margin66.3%Operating margin20.5%Net margin13.5%Free cash flow margin21.9%Fiscal year 2020Gross margin65.4%Operating margin21.3%Net margin31.0%Free cash flow margin20.8%Fiscal year 2021Gross margin68.0%Operating margin25.5%Net margin15.1%Free cash flow margin33.1%Fiscal year 2022Gross margin68.4%Operating margin26.8%Net margin24.6%Free cash flow margin25.4%Fiscal year 2023Gross margin67.7%Operating margin26.3%Net margin25.1%Free cash flow margin19.0%Fiscal year 2024Gross margin66.4%Operating margin17.8%Net margin14.5%Free cash flow margin20.4%Fiscal year 2025Gross margin64.8%Operating margin8.4%Net margin6.0%Free cash flow margin21.0%Fiscal year 2026Gross margin65.8%Operating margin20.7%Net margin15.0%Free cash flow margin21.7%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Gross margin 66.5% 67.2% 66.3% 65.4% 68.0% 68.4% 67.7% 66.4% 64.8% 65.8%
Operating margin 21.4% 21.2% 20.5% 21.3% 25.5% 26.8% 26.3% 17.8% 8.4% 20.7%
Net margin 13.5% 19.6% 13.5% 31.0% 15.1% 24.6% 25.1% 14.5% 6.0% 15.0%
Free cash flow margin 22.8% 23.2% 21.9% 20.8% 33.1% 25.4% 19.0% 20.4% 21.0% 21.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow143.7Capital expenditure−15.2Free cash flow128.5Dividends paid−47.3Fiscal year 2018Operating cash flow170.4Capital expenditure−20.9Free cash flow149.4 +16.3%Buybacks0.0Dividends paid−48.0Fiscal year 2019Operating cash flow181.6Capital expenditure−25.4Free cash flow156.2 +4.5%Buybacks−15.4Dividends paid−48.4Fiscal year 2020Operating cash flow205.2Capital expenditure−51.7Free cash flow153.5 −1.8%Buybacks−50.1Dividends paid−48.9Fiscal year 2021Operating cash flow352.2Capital expenditure−44.3Free cash flow307.9 +100.6%Buybacks−43.2Dividends paid−49.6Fiscal year 2022Operating cash flow325.3Capital expenditure−44.9Free cash flow280.4 −8.9%Buybacks−161.0Dividends paid−50.2Fiscal year 2023Operating cash flow254.4Capital expenditure−38.2Free cash flow216.1 −22.9%Buybacks−19.6Dividends paid−50.3Fiscal year 2024Operating cash flow299.0Capital expenditure−62.9Free cash flow236.1 +9.2%Buybacks−80.0Dividends paid−50.4Fiscal year 2025Operating cash flow287.6Capital expenditure−31.0Free cash flow256.6 +8.7%Buybacks−275.7Dividends paid−50.4Fiscal year 2026Operating cash flow292.1Capital expenditure−28.9Free cash flow263.2 +2.6%Buybacks−41.7Dividends paid−49.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow 143.7 170.4 181.6 205.2 352.2 325.3 254.4 299.0 287.6 292.1
Capital expenditure −15.2 −20.9 −25.4 −51.7 −44.3 −44.9 −38.2 −62.9 −31.0 −28.9
Free cash flow 128.5 149.4 156.2 153.5 307.9 280.4 216.1 236.1 256.6 263.2
Growth +16.3% +4.5% −1.8% +100.6% −8.9% −22.9% +9.2% +8.7% +2.6%
Buybacks n/a 0.0 −15.4 −50.1 −43.2 −161.0 −19.6 −80.0 −275.7 −41.7
Dividends paid −47.3 −48.0 −48.4 −48.9 −49.6 −50.2 −50.3 −50.4 −50.4 −49.9

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash91.6Shareholders’ equity949.6Fiscal year 2018Cash122.0Shareholders’ equity1,079.1Fiscal year 2019Cash100.9Total debt12.5Net cash (debt)88.4Shareholders’ equity1,165.6Debt to equity0.01Fiscal year 2020Cash146.6Total debt12.5Net cash (debt)134.1Shareholders’ equity1,381.2Debt to equity0.01Fiscal year 2021Cash199.1Total debt12.5Net cash (debt)186.6Shareholders’ equity1,563.0Debt to equity0.01Fiscal year 2022Cash172.6Total debt12.5Net cash (debt)160.1Shareholders’ equity1,701.8Debt to equity0.01Fiscal year 2023Cash180.6Shareholders’ equity1,966.5Fiscal year 2024Cash151.8Shareholders’ equity2,068.9Fiscal year 2025Cash162.2Shareholders’ equity1,918.8Fiscal year 2026Cash264.7Shareholders’ equity2,108.2
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 91.6 122.0 100.9 146.6 199.1 172.6 180.6 151.8 162.2 264.7
Total debt n/a n/a 12.5 12.5 12.5 12.5 n/a n/a n/a n/a
Net cash (debt) n/a n/a 88.4 134.1 186.6 160.1 n/a n/a n/a n/a
Shareholders’ equity 949.6 1,079.1 1,165.6 1,381.2 1,563.0 1,701.8 1,966.5 2,068.9 1,918.8 2,108.2
Debt to equity n/a n/a 0.01 0.01 0.01 0.01 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021† 30 Jun 2021 FY2022 30 Jun 2022 FY2023 30 Jun 2023 FY2024 30 Jun 2024 FY2025 30 Jun 2025 FY2026 30 Jun 2026
Assets
91.6 122.0 100.9 146.6 199.1 172.6 180.6 151.8 162.2 264.7
116.8 120.3 137.5 122.5 145.4 194.5 218.5 241.4 206.9 216.6
60.2 85.6 91.1 103.2 116.7 141.1 171.6 179.7 189.4 195.7
135.1 145.3 154.0 176.8 207.9 223.2 226.2 251.2 245.7 231.8
579.0 597.9 732.7 728.3 843.1 822.1 872.7 972.7 980.9 975.4
1,558.2 1,593.2 1,884.4 2,027.6 2,263.0 2,294.8 2,638.7 2,703.9 2,557.9 2,586.7
Growth +2.2% +18.3% +7.6% +11.6% +1.4% +15.0% +2.5% −5.4% +1.1%
Liabilities
n/a n/a 12.5 12.5 12.5 12.5 n/a n/a n/a n/a
calc n/a n/a 12.5 12.5 12.5 12.5 n/a n/a n/a n/a
Equity
799.0 876.9 931.9 1,057.5 1,085.5 1,122.9 1,309.5 1,325.2 1,066.0 1,144.2
949.6 1,079.1 1,165.6 1,381.2 1,563.0 1,701.8 1,966.5 2,068.9 1,918.8 2,108.2
Growth +13.6% +8.0% +18.5% +13.2% +8.9% +15.6% +5.2% −7.3% +9.9%
Per share and net cash
calc n/a n/a 88.4 134.1 186.6 160.1 n/a n/a n/a n/a
37.4 37.6 37.9 38.5 39.0 156.6 157.6 158.2 155.0 156.1
calc 25.42 28.69 30.73 35.92 40.12 10.86 12.47 13.08 12.38 13.51

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.